Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
LENSAR Inc

LENSAR Inc (LNSR) Stock Overview

Explore LENSAR Inc’s financial performance, market position, analyst ratings, and future outlook.

LNSR●NASDAQ
HealthcareMedical - Equipment & Services
$6.04
$0.30(5.32%)
U.S. Market opens in 49h 44m

LENSAR Inc (LNSR)

Meyka AI Score

Z

Key Financials

Market Cap74.2M
P/E Ratio6.02
EPS (TTM)$0.98
ROE-5.15%
Fundamental Analysis

AI Price Forecasts

1 Month$5.18
3 Months$1.20
1 Year Target$4.12

LNSR Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of LENSAR Inc (NASDAQ: LNSR) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, LENSAR Inc's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of LNSR on the NASDAQ shows an RSI of 59.74, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $4.12 for the NASDAQ listing.

Key metrics behind LENSAR Inc's NASDAQ-traded stock include a P/E ratio of 6.02 and a market capitalization of 74.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of LNSR on the NASDAQ.

Price Performance (NASDAQ: LNSR)

1-Day Change
5.32%
5-Day Change
16.38%
1-Month Change
-1.47%
3-Month Change
15.49%
6-Month Change
-50.00%
Year-to-Date (YTD) Change
-48.07%
1-Year Change
-52.96%
3-Year Change
94.21%
5-Year Change
-27.49%
All-Time (Max) Change
-32.89%

Contact Information

https://www.lensar.com
888 536 7271
2800 Discovery Drive, Orlando, FL, 32826

Company Facts

1,500 Employees
IPO DateOct 2, 2020
CountryUS
Actively Trading

Frequently Asked Questions